3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder - sprookjes - yvandenbroek - TriplyDB

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

http://www.wikidata.org/entity/Q22299243

about

The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.The intersection of structurally traumatized communities and substance use treatment: Dominant discourses and hidden themes.

P2860

Q28069364-CEB59F6F-390F-4DB3-AD95-E3F82FF42EBB Q39026719-49977A17-8B29-4AE2-94B0-322306CC172D Q47410020-9F7E35A7-76B8-4BE7-870E-54121F7D6BD6 Q50064387-05A13E5F-1E34-4BD7-856F-D46F0CFED368 Q51339121-6DC3C4CF-1A38-47C0-8E10-4FC2418545E4

P2860

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

http://www.wikidata.org/entity/Q22299243

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@ast

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@en

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@en-gb

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@nl

type

label

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@ast

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@en

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@en-gb

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@nl

prefLabel

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@ast

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@en

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@en-gb

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@nl

P1433

Q22299243-7739EA42-B717-45BC-B03E-A5BF958A09BC

P1476

Q22299243-E098DEE5-FA36-4EDD-A904-5039AB11FE27

P2093

Q22299243-409EBCB5-B35A-4FBB-94AD-52E6407DE908

P2860

Q22299243-0524FD23-6EE0-47DB-A800-A4F6C977B760

Q22299243-06863261-D98A-4CFF-BB55-B47B4BE59E5D

Q22299243-0C215FA3-8514-437B-B363-723D70E418C5

Q22299243-0E05C085-A4A6-41A7-93FB-84CC6931BB75

Q22299243-15DBE445-8D18-4EE6-8EDA-2779A5B6D2B5

Q22299243-2014DD2E-77B8-49AD-9F50-7AEE7DC66729

Q22299243-34711B4E-8129-43AB-B6D4-038FD4FD914E

Q22299243-37E4DE0B-231F-42F7-8C38-CDD3E76B27CC

Q22299243-48B0665A-1AF3-419D-A451-2C8075C6BB65

Q22299243-580749E9-6140-4DBD-BEC6-BA698D612270

P304

Q22299243-92120F73-2A7E-438F-9AEC-A10356EB3A55

P31

Q22299243-BCE52470-AF9B-4937-874D-85D4951CBE6E

P3181

Q22299243-55595962-769D-451F-AC6E-0716128488F6

P356

Q22299243-E86FD17C-ABDC-4B88-8559-D33C33F4BD58

P407

Q22299243-83A1CD91-3CC3-4C1E-BF77-D1B3DEF401C2

P433

Q22299243-50F23F4C-091F-4328-A448-7A781F41A6A6

P478

Q22299243-F386FCCB-4C20-4C09-9EBA-2B0DB8E98B7E

P577

Q22299243-0C28A917-A1CD-4225-AB82-B24F58EA124A

P698

Q22299243-2997DF53-CDCC-4F22-852D-625254AD76DC

P3181

P356

1060028014532236

P1433

Annals of Pharmacotherapy

P1476

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder

@en

P2093

C. M. White

http://www.w3.org/2001/XMLSchema#string

P2860

Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

Posttraumatic stress disorder in the National Comorbidity Survey

How MDMA's pharmacology and pharmacokinetics drive desired effects and harms.

Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.

Anxiety online: a virtual clinic: preliminary outcomes following completion of five fully automated treatment programs for anxiety disorders and symptoms

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.

The development of a Clinician-Administered PTSD Scale.

P304

908-915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3850753

http://www.w3.org/2001/XMLSchema#string

P356

10.1177/1060028014532236

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24740469

http://www.w3.org/2001/XMLSchema#string